Vasopressin Effects on Human Social Communication

• Status: Completed
• Trial end date: 2017-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This research is being done because we wish to understand how a chemical produced in the brain, vasopressin, effects emotional social communication processes. Understanding how this system works in normal individuals may help us understand why some people, particularly those with autism and/or antisocial personality disorder, have dysfunctional social interactions.

This study will test the effects of 3 doses of arginine vasopressin, delivered intranasally, on physiological and behavioral responses to the faces of same- and other-sex individuals in healthy men and women.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bowdoin College
• Collaborators: Maine Medical Center; MaineHealth; National Institute of Mental Health (NIMH)
• Treatments: Arginine Vasopressin; Vasopressins

Criteria

Inclusion Criteria:

• Healthy men and women 21-30 years of age

Exclusion Criteria:

• individuals with high blood pressure or a history of seizures

• allergies

• heart problems

• psychiatric problems

• drug abuse

• pregnant All subjects will be given a preliminary medical and psychiatric exam as well as drug and (for women) pregnancy test